Home/DeuterOncology/Els Hubloux Chier

EH

Els Hubloux Chier

Financial Officer

Therapeutic Areas

Oncology Lung Cancer

DeuterOncology Pipeline

Drug	Indication	Phase
DO-2	MET-altered NSCLC & Advanced Solid Tumors	Phase 1
DO-1	Not specified	Pre-clinical

Leadership Team at DeuterOncology

Dr Timothy Perera

Founder & Chief Executive Officer

Prof Jaap Verweij

Chief Medical Officer

View full DeuterOncology profile